CNBX Pharmaceuticals CNBX Income Statement (2011-2026)

OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement May2011 Aug2011 Nov2011 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026
Revenue & cost
Revenue (Quarter)
0.03M0.31M0.10M0.09M0.04M
Cost of Revenue (Quarter)
0.01M
Gross Profit (Quarter)
0.03M
Operating items
Research & Development (Quarter)
0.47M0.44M0.33M0.25M0.16M0.06M0.01M0.26M0.09M0.11M0.11M0.04M-0.07M
Selling, General & Administrative (Quarter)
0.13M0.67M0.40M0.39M0.34M0.28M0.24M0.22M0.17M0.15M0.13M0.11M0.13M0.04M0.06M0.04M0.13M0.06M0.07M0.16M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
-1.00
Operating Expenses (Quarter)
0.60M1.11M0.73M0.64M0.51M0.35M0.25M0.48M0.26M0.26M0.24M0.15M0.05M0.04M0.06M0.04M0.13M0.06M0.07M0.16M
Operating Income (Quarter)
-0.60M-1.11M-0.73M-0.64M-0.48M-0.35M-0.25M-0.17M-0.16M-0.17M-0.21M-0.15M-0.05M-0.04M-0.06M-0.04M-0.13M-0.06M-0.07M-0.16M
EBIT (Quarter)
-0.60M-1.11M-0.73M-0.64M-0.48M-0.35M-0.25M-0.17M-0.16M-0.17M-0.21M-0.15M-0.05M-0.04M-0.06M-0.04M-0.13M-0.06M-0.07M-0.16M
Non-operating items
Other Non Operating Income (Quarter)
-0.79M-0.21M-0.51M-0.05M-0.01M0.02M0.02M-0.01M0.00M0.02M0.00M-0.01M-0.02M-0.05M0.03M0.01M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-0.68M-1.11M-1.24M-0.68M-0.49M-0.35M-0.25M-0.16M-0.16M-0.18M-0.21M-0.15M-0.06M-0.04M-0.07M-0.05M-3.67M-0.11M-0.04M-0.16M
Profit After Tax (Quarter)
-0.68M-1.32M-1.61M-0.68M-1.15M-0.42M-2.62M-0.15M-0.51M-0.18M-0.33M-0.13M-0.06M-0.03M-0.07M-0.06M-0.15M-0.11M-0.04M-0.15M
Income from Non-Controlling Interests (Quarter)
-0.14M-0.28M-0.37M0.04M-0.06M-0.06M0.06M
Income from Continuing Operations (Quarter)
-0.68M-1.11M-1.24M-0.68M-0.49M-0.35M-0.25M-0.16M-0.16M-0.18M-0.21M-0.15M-0.06M-0.04M-0.07M-0.05M-3.67M-0.11M-0.04M-0.16M
Consolidated Net Income (Quarter)
-0.68M-1.11M-1.24M-0.68M-0.49M-0.35M-0.25M-0.16M-0.16M-0.18M-0.21M-0.15M-0.06M-0.04M-0.07M-0.05M-3.67M-0.11M-0.04M-0.16M
Income towards Parent Company (Quarter)
-0.68M-1.11M-1.24M-0.68M-0.49M-0.35M-0.25M-0.16M-0.16M-0.18M-0.21M-0.15M-0.06M-0.04M-0.07M-0.05M-3.67M-0.11M-0.04M-0.16M
Net Income towards Common Stockholders (Quarter)
-0.68M-1.11M-1.24M-0.68M-0.49M-0.35M-0.25M-0.16M-0.16M-0.18M-0.21M-0.15M-0.06M-0.04M-0.07M-0.05M-3.67M-0.11M-0.04M-0.16M
Additional items
EPS (Basic) (Quarter)
0.00-0.01-0.01-0.55-0.40-0.28-0.13-0.02-0.02-0.01-0.010.000.000.000.000.00-0.040.000.000.00
EPS (Diluted) (Quarter)
0.00-0.01-1.01-0.55-0.40-0.28-0.13-0.02-0.02-0.01-0.010.000.000.000.000.00-0.040.000.000.00
Shares Outstanding (Quarter)
138.52M144.73M147.14M1.24M1.22M1.26M1.96M9.27M8.82M27.76M30.99M31.11M30.25M31.11M32.10M42.60M90.65M732.86M931.02M1,318.59M
Shares Outstanding (Diluted) (Quarter)
138.52M131.11M1.23M1.24M1.22M1.26M1.96M9.27M8.82M27.76M30.99M31.11M30.25M31.11M32.10M42.60M90.65M732.86M931.02M1,318.59M
Shares Outstanding (Entity) (Quarter)
144.75M156.38M147.15M1.24M1.24M1.24M2.19M9.27M8.82M28.31M31.11M31.11M31.11M31.11M33.86M42.60M90.65M753.20M931.02M1,475.77M
EBITDA (Quarter)
-0.60M-1.11M-0.73M-0.64M-0.48M-0.35M-0.25M-0.17M-0.16M-0.17M-0.21M-0.15M-0.05M-0.04M-0.06M-0.04M-0.13M-0.06M-0.07M-0.16M
Interest Expenses (Quarter)
0.08M0.51M0.05M0.01M0.00M0.00M-0.01M0.00M0.01M0.01M0.01M0.00M0.00M0.01M3.54M0.05M-0.03M